Pharm'Up

Panjab University Seeks Guest Faculty for M.Sc. Microbial Biotechnology: Rs. 50,000/Month Honorarium

2 min read

• Pharma Jobs

Panjab University Seeks Guest Faculty for M.Sc. Microbial Biotechnology: Rs. 50,000/Month Honorarium

Pharm'Up

The Department of Microbial Biotechnology at Panjab University, Chandigarh (South Campus, Sector-25) has invited applications for the...

Read More Read more about Panjab University Seeks Guest Faculty for M.Sc. Microbial Biotechnology: Rs. 50,000/Month Honorarium

High-Value Research Opportunity JIPMER Seeks Project Research Scientist for ICMR-Funded Trauma Care Study

2 min read

• Pharma Jobs

High-Value Research Opportunity JIPMER Seeks Project Research Scientist for ICMR-Funded Trauma Care Study

Pharm'Up

The Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER) has invited applications for the position of...

Read More Read more about High-Value Research Opportunity JIPMER Seeks Project Research Scientist for ICMR-Funded Trauma Care Study

Novo Nordisk Partners with Emcure Pharma to Double Access to Semaglutide (Wegovy®) in India

2 min read

• Industries
• Pharma News

Novo Nordisk Partners with Emcure Pharma to Double Access to Semaglutide (Wegovy®) in India

Pharm'Up

Novo Nordisk India and Emcure Pharma have announced a strategic partnership to significantly expand the availability of...

Read More Read more about Novo Nordisk Partners with Emcure Pharma to Double Access to Semaglutide (Wegovy®) in India

Landmark VESALIUS-CV Trial: Repatha Becomes First PCSK9 Inhibitor to Slash Primary Heart Event Risk by 25%

2 min read

• Industries
• Pharma News

Landmark VESALIUS-CV Trial: Repatha Becomes First PCSK9 Inhibitor to Slash Primary Heart Event Risk by 25%

Pharm'Up

Amgen has announced detailed, pivotal results from its Phase 3 VESALIUS-CV clinical trial, proving that Repatha® (evolocumab)...

Read More Read more about Landmark VESALIUS-CV Trial: Repatha Becomes First PCSK9 Inhibitor to Slash Primary Heart Event Risk by 25%

Zydus Marks Strategic Entry into China with NMPA Approval for Venlafaxine ER Capsules

1 min read

• Industries
• Pharma News

Zydus Marks Strategic Entry into China with NMPA Approval for Venlafaxine ER Capsules

Pharm'Up

Zydus Lifesciences Limited has achieved a pivotal regulatory and commercial breakthrough by securing its first-ever approval from...

Read More Read more about Zydus Marks Strategic Entry into China with NMPA Approval for Venlafaxine ER Capsules

Breakthrough in Cardiac Care Personalized Vitamin D3 Treatment Halves Recurrent Heart Attack Risk

2 min read

• Pharma News

Breakthrough in Cardiac Care Personalized Vitamin D3 Treatment Halves Recurrent Heart Attack Risk

Pharm'Up

A groundbreaking study conducted by heart researchers at Intermountain Health has revealed that a personalized, “target to...

Read More Read more about Breakthrough in Cardiac Care Personalized Vitamin D3 Treatment Halves Recurrent Heart Attack Risk

Advocating for Home-Based Kidney Care A Roadmap for Scaling Peritoneal Dialysis (PD) in India

2 min read

• Pharma News

Advocating for Home-Based Kidney Care A Roadmap for Scaling Peritoneal Dialysis (PD) in India

Pharm'Up

A new Advocacy Paper, developed by leading nephrology experts, outlines a strategic roadmap to overcome the barriers...

Read More Read more about Advocating for Home-Based Kidney Care A Roadmap for Scaling Peritoneal Dialysis (PD) in India

Sandoz Strengthens Oncology Portfolio with Global License for Pertuzumab Biosimilar

2 min read

• Industries
• Pharma News

Sandoz Strengthens Oncology Portfolio with Global License for Pertuzumab Biosimilar

Pharm'Up

Sandoz, the global leader in affordable medicines, has announced a significant expansion of its oncology pipeline by...

Read More Read more about Sandoz Strengthens Oncology Portfolio with Global License for Pertuzumab Biosimilar

Zydus Lifesciences Secures USFDA Final Approval for Diroximel Fumarate Capsules

1 min read

• Pharma News

Zydus Lifesciences Secures USFDA Final Approval for Diroximel Fumarate Capsules

Pharm'Up

Zydus Lifesciences Limited has announced a significant regulatory milestone, having received final approval from the United States...

Read More Read more about Zydus Lifesciences Secures USFDA Final Approval for Diroximel Fumarate Capsules

Alkem Laboratories Delivers Robust Q2 FY26 Results with Double-Digit Growth

2 min read

• Pharma News

Alkem Laboratories Delivers Robust Q2 FY26 Results with Double-Digit Growth

Pharm'Up

Alkem Laboratories Ltd. has posted a robust performance for the second quarter ended September 30, 2025 (Q2...

Read More Read more about Alkem Laboratories Delivers Robust Q2 FY26 Results with Double-Digit Growth